172 related articles for article (PubMed ID: 36169924)
1. Doxorubicin-Loaded Polymeric Meshes Prevent Local Recurrence after Sarcoma Resection While Avoiding Cardiotoxicity.
Bressler EM; Chu NQ; Sabatelle RC; Mahvi DA; Korunes-Miller JT; Nagashima F; Ichinose F; Liu R; Grinstaff MW; Colson YL; Raut CP
Cancer Res; 2022 Dec; 82(23):4474-4484. PubMed ID: 36169924
[TBL] [Abstract][Full Text] [Related]
2. A prospective randomized trial of adjuvant chemotherapy with bolus versus continuous infusion of doxorubicin in patients with high-grade extremity soft tissue sarcoma and an analysis of prognostic factors.
Casper ES; Gaynor JJ; Hajdu SI; Magill GB; Tan C; Friedrich C; Brennan MF
Cancer; 1991 Sep; 68(6):1221-9. PubMed ID: 1873773
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel-eluting polymer film reduces locoregional recurrence and improves survival in a recurrent sarcoma model: a novel investigational therapy.
Liu R; Wolinsky JB; Catalano PJ; Chirieac LR; Wagner AJ; Grinstaff MW; Colson YL; Raut CP
Ann Surg Oncol; 2012 Jan; 19(1):199-206. PubMed ID: 21769471
[TBL] [Abstract][Full Text] [Related]
4. Prospective Evaluation of Doxorubicin Cardiotoxicity in Patients with Advanced Soft-tissue Sarcoma Treated in the ANNOUNCE Phase III Randomized Trial.
Jones RL; Wagner AJ; Kawai A; Tamura K; Shahir A; Van Tine BA; Martín-Broto J; Peterson PM; Wright J; Tap WD
Clin Cancer Res; 2021 Jul; 27(14):3861-3866. PubMed ID: 33632930
[TBL] [Abstract][Full Text] [Related]
5. Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
Posch F; Leitner L; Bergovec M; Bezan A; Stotz M; Gerger A; Pichler M; Stöger H; Liegl-Atzwanger B; Leithner A; Szkandera J
Clin Orthop Relat Res; 2017 May; 475(5):1427-1435. PubMed ID: 28083752
[TBL] [Abstract][Full Text] [Related]
6. A complex micellar system co-delivering curcumin with doxorubicin against cardiotoxicity and tumor growth.
Zhang D; Xu Q; Wang N; Yang Y; Liu J; Yu G; Yang X; Xu H; Wang H
Int J Nanomedicine; 2018; 13():4549-4561. PubMed ID: 30127606
[TBL] [Abstract][Full Text] [Related]
7. What Is the Success of Repeat Surgical Treatment of a Local Recurrence After Initial Wide Resection of Soft Tissue Sarcomas?
Sugiura H; Tsukushi S; Yoshida M; Nishida Y
Clin Orthop Relat Res; 2018 Sep; 476(9):1791-1800. PubMed ID: 30794216
[TBL] [Abstract][Full Text] [Related]
8. Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial.
Seddon B; Strauss SJ; Whelan J; Leahy M; Woll PJ; Cowie F; Rothermundt C; Wood Z; Benson C; Ali N; Marples M; Veal GJ; Jamieson D; Küver K; Tirabosco R; Forsyth S; Nash S; Dehbi HM; Beare S
Lancet Oncol; 2017 Oct; 18(10):1397-1410. PubMed ID: 28882536
[TBL] [Abstract][Full Text] [Related]
9. Patterns of recurrence in patients with high-grade soft-tissue sarcomas.
Potter DA; Glenn J; Kinsella T; Glatstein E; Lack EE; Restrepo C; White DE; Seipp CA; Wesley R; Rosenberg SA
J Clin Oncol; 1985 Mar; 3(3):353-66. PubMed ID: 3973646
[TBL] [Abstract][Full Text] [Related]
10. First-Line Aldoxorubicin vs Doxorubicin in Metastatic or Locally Advanced Unresectable Soft-Tissue Sarcoma: A Phase 2b Randomized Clinical Trial.
Chawla SP; Papai Z; Mukhametshina G; Sankhala K; Vasylyev L; Fedenko A; Khamly K; Ganjoo K; Nagarkar R; Wieland S; Levitt DJ
JAMA Oncol; 2015 Dec; 1(9):1272-80. PubMed ID: 26378637
[TBL] [Abstract][Full Text] [Related]
11. Prevention of local tumor recurrence following surgery using low-dose chemotherapeutic polymer films.
Liu R; Wolinsky JB; Walpole J; Southard E; Chirieac LR; Grinstaff MW; Colson YL
Ann Surg Oncol; 2010 Apr; 17(4):1203-13. PubMed ID: 19957041
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
Bramwell V; Rouesse J; Steward W; Santoro A; Schraffordt-Koops H; Buesa J; Ruka W; Priario J; Wagener T; Burgers M
J Clin Oncol; 1994 Jun; 12(6):1137-49. PubMed ID: 8201375
[TBL] [Abstract][Full Text] [Related]
13. A phase II clinical study of 13-deoxy, 5-iminodoxorubicin (GPX-150) with metastatic and unresectable soft tissue sarcoma.
Van Tine BA; Agulnik M; Olson RD; Walsh GM; Klausner A; Frank NE; Talley TT; Milhem MM
Cancer Med; 2019 Jun; 8(6):2994-3003. PubMed ID: 31016866
[TBL] [Abstract][Full Text] [Related]
14. Temperature-Responsive Polymersomes of Poly(3-methyl-
Kozlovskaya V; Liu F; Yang Y; Ingle K; Qian S; Halade GV; Urban VS; Kharlampieva E
Biomacromolecules; 2019 Oct; 20(10):3989-4000. PubMed ID: 31503464
[TBL] [Abstract][Full Text] [Related]
15. (-)-Epigallocatechin-3-gallate alleviates doxorubicin-induced cardiotoxicity in sarcoma 180 tumor-bearing mice.
Yao YF; Liu X; Li WJ; Shi ZW; Yan YX; Wang LF; Chen M; Xie MY
Life Sci; 2017 Jul; 180():151-159. PubMed ID: 27956351
[TBL] [Abstract][Full Text] [Related]
16. Individualized doxorubicin sensitivity testing of undifferentiated soft tissue sarcoma (USTS) in a patient-derived orthotopic xenograft (PDOX) model demonstrates large differences between patients.
Kawaguchi K; Igarashi K; Kiyuna T; Miyake K; Miyake M; Murakami T; Chmielowski B; Nelson SD; Russell TA; Dry SM; Li Y; Singh AS; Unno M; Eilber FC; Hoffman RM
Cell Cycle; 2018; 17(5):627-633. PubMed ID: 29384032
[TBL] [Abstract][Full Text] [Related]
17. [Retroperitoneal soft tissue sarcoma: surgical management].
Willis F; Schneider M
Chirurg; 2022 Jan; 93(1):16-26. PubMed ID: 34596706
[TBL] [Abstract][Full Text] [Related]
18. Olaratumab combined with doxorubicin and ifosfamide overcomes individual doxorubicin and olaratumab resistance of an undifferentiated soft-tissue sarcoma in a PDOX mouse model.
Higuchi T; Miyake K; Sugisawa N; Oshiro H; Zhang Z; Razmjooei S; Yamamoto N; Hayashi K; Kimura H; Miwa S; Igarashi K; Bouvet M; Singh SR; Tsuchiya H; Hoffman RM
Cancer Lett; 2019 Jun; 451():122-127. PubMed ID: 30867142
[TBL] [Abstract][Full Text] [Related]
19. Impact of margin status and local recurrence on soft-tissue sarcoma outcomes.
Potter BK; Hwang PF; Forsberg JA; Hampton CB; Graybill JC; Peoples GE; Stojadinovic A
J Bone Joint Surg Am; 2013 Oct; 95(20):e151. PubMed ID: 24132366
[TBL] [Abstract][Full Text] [Related]
20. High dose, dual-release polymeric films for extended surgical bed paclitaxel delivery.
Mahvi DA; Korunes-Miller J; Bordeianu C; Chu NQ; Geller AD; Sabatelle R; Berry S; Hung YP; Colson YL; Grinstaff MW; Raut CP
J Control Release; 2023 Nov; 363():682-691. PubMed ID: 37776906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
